Presentation is loading. Please wait.

Presentation is loading. Please wait.

Fig 1 Percentage of patients in the combined modified intent-to-treat population with efficacy endpoints accounting specifically for nausea, by treatment.

Published byAlexina Garrett Modified over 6 years ago

Similar presentations

Presentation on theme: "Fig 1 Percentage of patients in the combined modified intent-to-treat population with efficacy endpoints accounting specifically for nausea, by treatment."— Presentation transcript:

1 Fig 1 Percentage of patients in the combined modified intent-to-treat population with efficacy endpoints accounting specifically for nausea, by treatment group. VRS, verbal rating scale. *An odds ratio (aprepitant:ondansetron) >1.0, P<0.05 in favour of aprepitant (from Diemunsch and colleagues).<sup>13</sup> From: Neurokinin-1 receptor antagonists in the prevention of postoperative nausea and vomiting Br J Anaesth. 2009;103(1):7-13. doi: /bja/aep125 Br J Anaesth | © The Author [2009]. Published by Oxford University Press on behalf of The Board of Directors of the British Journal of Anaesthesia. All rights reserved. For Permissions, please 1

Download ppt "Fig 1 Percentage of patients in the combined modified intent-to-treat population with efficacy endpoints accounting specifically for nausea, by treatment."

Similar presentations

From: An open day in the metric space

From: An open day in the metric space
Fig. 1 Flow chart of the COBRA-light trial and its extension study

Fig. 1 Flow chart of the COBRA-light trial and its extension study
Fig. 1 Graphical representation

Fig. 1 Graphical representation
Fig 2 Task related processing times of naïve operators (blue) and experienced operators (orange) given for the four anaesthesia ventilators in the order.

Fig 2 Task related processing times of naïve operators (blue) and experienced operators (orange) given for the four anaesthesia ventilators in the order.
Fig 1 Trends in organ donors in the UK, 2000–10

Fig 1 Trends in organ donors in the UK, 2000–10
From: Political Leadership and Power Redistribution

From: Political Leadership and Power Redistribution
Fig 1 The CONSORT participant flow diagram for primary endpoints.

Fig 1 The CONSORT participant flow diagram for primary endpoints.
Fig. 1 Examples of Insulin pump systems

Fig. 1 Examples of Insulin pump systems
pSS: primary SS; Scl: scleroderma.

pSS: primary SS; Scl: scleroderma.
Figure 1. Selection of papers.

Figure 1. Selection of papers.
Fig. 1 Flow chart of study selection

Fig. 1 Flow chart of study selection
Figure 1. (A) Forest plot of common odds ratios (adjusted for ECOG PS) for best overall response by a priori subgroups in patients with KRAS wild-type.

Figure 1. (A) Forest plot of common odds ratios (adjusted for ECOG PS) for best overall response by a priori subgroups in patients with KRAS wild-type.
Fig. 1 Flow of ascertainment of cases with incident childhood IgA vasculitis reported by four sources From: Incidence of IgA vasculitis in children estimated.

Fig. 1 Flow of ascertainment of cases with incident childhood IgA vasculitis reported by four sources From: Incidence of IgA vasculitis in children estimated.
Fig. 1. Geographic locations of Shenzhen and Dongguan

Fig. 1. Geographic locations of Shenzhen and Dongguan
Fig 1 Respiratory support escalation strategies for study patients

Fig 1 Respiratory support escalation strategies for study patients
Fig 1 Effect of ketamine on the sufentanil enhancement of mechanical hyperalgesia (protocol A). No difference in the measured parameter was observed in.

Fig 1 Effect of ketamine on the sufentanil enhancement of mechanical hyperalgesia (protocol A). No difference in the measured parameter was observed in.
Fig 1 Perfusion index values at different time intervals in patients with successful and failed blocks. A reference line at PI 3.3 is provided. Horizontal.

Fig 1 Perfusion index values at different time intervals in patients with successful and failed blocks. A reference line at PI 3.3 is provided. Horizontal.
Figure 1 Flow chart showing the selection of publications identified in the literature search. From: GnRH antagonist versus long agonist protocols in IVF:

Figure 1 Flow chart showing the selection of publications identified in the literature search. From: GnRH antagonist versus long agonist protocols in IVF:
Fig 2 Blood gas analysis during transnasal humidified rapid insufflation ventiror exchange (70 l min−1), and 1 min after oxygenation (12 l min−1)

Fig 2 Blood gas analysis during transnasal humidified rapid insufflation ventiror exchange (70 l min−1), and 1 min after oxygenation (12 l min−1)
Fig 1 Coding search and excluded records.

Fig 1 Coding search and excluded records.

Similar presentations

Ads by Google